A pharmaceutical company says a drug that may potentially treat and prevent the coronavirus is now in the human testing stages and could be ready this year.

CNN reported Thursday that Regeneron Pharmaceutical Inc. aims to make the cocktail available by the fall if the trials are successful.

“We have created a unique anti-viral antibody cocktail with the potential both to prevent and treat infection and also to preempt viral ‘escape,’ a critical precaution in the midst of an ongoing global pandemic,” Dr. George Yancopoulos, Regeneron’s co-founder, president and chief scientific officer, said in a statement, CNN reported.

Did you like this story?
Would you like to receive articles like this in your inbox? Free!

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published. Required fields are marked *